Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Aug 9:5:163-71.
doi: 10.2147/cia.s8100.

Update on the management of constipation in the elderly: new treatment options

Satish S C Rao  1 , Jorge T Go
Affiliations
Review

Update on the management of constipation in the elderly: new treatment options

Satish S C Rao et al. Clin Interv Aging. .

Abstract

Constipation disproportionately affects older adults, with a prevalences of 50% in community-dwelling elderly and 74% in nursing-home residents. Loss of mobility, medications, underlying diseases, impaired anorectal sensation, and ignoring calls to defecate are as important as dyssynergic defecation or irritable bowel syndrome in causing constipation. Detailed medical history on medications and co-morbid problems, and meticulous digital rectal examination may help identify causes of constipation. Likewise, blood tests and colonoscopy may identify organic causes such as colon cancer. Physiological tests such as colonic transit study with radio-opaque markers or wireless motility capsule, anorectal manometry, and balloon expulsion tests can identify disorders of colonic and anorectal function. However, in the elderly, there is usually more than one mechanism, requiring an individualized but multifactorial treatment approach. The management of constipation continues to evolve. Although osmotic laxatives such as polyethylene glycol remain mainstay, several new agents that target different mechanisms appear promising such as chloride-channel activator (lubiprostone), guanylate cyclase agonist (linaclotide), 5HT(4) agonist (prucalopride), and peripherally acting mu-opioid receptor antagonists (alvimopan and methylnaltrexone) for opioid-induced constipation. Biofeedback therapy is efficacious for treating dyssynergic defecation and fecal impaction with soiling. However, data on efficacy and safety of drugs in elderly are limited and urgently needed.

Keywords: constipation; elderly; treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Treatment algorithm for the management of chronic constipation in the elderly.
See this image and copyright information in PMC

Comment in

References

    1. McCrea GL, Miaskowski C, Stotts NA, et al. Pathophysiology of constipation in the older adult. World J Gastroenterol. 2008;14(17):2631–2638. - PMC - PubMed
    1. Drossman DA, Sandler RS, McKee DC, et al. Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction. Gastroenterology. 1982;83(3):529–534. - PubMed
    1. Pare P, Ferrazzi S, Thompson WG, et al. An epidemiological survey of constipation in Canada: Definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol. 2001;96(11):3130–3137. - PubMed
    1. Bouras EP, Tangalos EG. Chronic constipation in the elderly. Gastroenterol Clin North Am. 2009;38(3):463–480. - PubMed
    1. Talley NJ, Fleming KC, Evans JM, et al. Constipation in an elderly community: A study of prevalence and potential risk factors. Am J Gastroenterol. 1996;91(1):19–25. - PubMed

Publication types